RPRenan Augusto Pereira

Renan Augusto Pereira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Renan Augusto Pereira has a total of 138 co-authors. Here are the top co-authors by number of shared publications:

  • Alejandro Lozano

    Universidad Católica de Córdoba, Córdoba, Argentina

    2 shared publications
  • Ana Trindade Winck

    De inteligência artificial Universidade Federal de Ciências da Saúde de Porto Alegre -Porto Alegre RS Brazil

    2 shared publications
  • Antonio Condino-Neto

    Hospital Das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    2 shared publications
  • Cecilia Montenegro

    Hospital de Pediatría del Centro Hospitalario Pereira Rossell, Montevideo, Uruguay

    2 shared publications
  • Daniel Mendoza-Quispe

    Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru

    2 shared publications
  • Diana Cabanillas

    Hospital de Niños Sor María Ludovica, Buenos Aires, Argentina

    2 shared publications

Latest Publications

  • Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter study

    by Renan A. Pereira, Ellen O. Dantas, Jessica Loekmanwidjaja, Juliana T. L. Mazzucchelli, Carolina S. Aranda, Maria E. G. Serrano, Elisabeth A. De La Cruz Córdoba, Liliana Bezrodnik, Ileana Moreira, Janaira F. S. Ferreira, et al.

    Ataxia-telangiectasia (AT) is a rare genetic disorder leading to neurological defects, telangiectasias, and immunodeficiency. We aimed to study the clinical and immunological features of Latin American patients with AT and analyze factors associated with mortality. Referral centers from 9 Latin American countries participated in this retrospective cohort study, and 218 patients were included. Median (IQR) ages at symptom onset and diagnosis were 1.0 (1.0–2.0) and 5.0 (3.0–8.0) years, respectively. Most patients presented recurrent airway infections, which was significantly associated with IgA deficiency. IgA deficiency was observed in 60.8% of patients and IgG deficiency in 28.6%. T- and B-lymphopenias were also present in most cases. Mean survival was 24.2 years, and Kaplan–Meier 20-year-survival rate was 52.6%, with higher mortality associated with female gender and low IgG levels. These findings suggest that immunologic status should be investigated in all patients with AT.


  • Open Access

    Food allergens on food product labels: unification of nomenclature

    by Renan Augusto Pereira, Flávia Magalhães Guedes, Giovana Alves Gadelha, Gabriel Menin, Guilherme Pereira Menezes, Sérgio Luis Amantéa, Ana Trindade Winck

    A revista Arquivos de Asma, Alergia e Imunologia tem a miss?o de divulgar estudos e informa??es relevantes na constru??o do conhecimento na ?rea de Alergia e Imunologia.


  • Open Access

    Alérgenos alimentares em rótulos de produtos alimentícios: uma unificação da nomenclatura

    by Renan Augusto Pereira, Flávia Magalhães Guedes, Giovana Alves Gadelha, Gabriel Menin, Guilherme Pereira Menezes, Sérgio Luis Amantéa, Ana Trindade Winck

    A revista Arquivos de Asma, Alergia e Imunologia tem a miss?o de divulgar estudos e informa??es relevantes na constru??o do conhecimento na ?rea de Alergia e Imunologia.

  • Open Access

    Ataxia Telangiectasia in Latin America: clinical features, immunodeficiency and mortality in a multicenter study

    by Renan Augusto Pereira, Ellen O Dantas, Jessica Loekmanwidjaja, Juliana T L Mazzucchelli, Carolina S Aranda, Maria E G Serrano, Liliana Bezrodnik, Ileana Moreira, Janaira F S Ferreira, Vera M Dantas, et al.

    Ataxia-telangiectasia (AT) is a rare neurodegenerative genetic disorder leading to neurological defects, telangiectasias and immunodeficiency. We aimed to study the clinical and immunological features of Latin American patients with AT and analyze the factors associated with AT-related mortality. Referral centers (n = 46) from 9 Latin American countries participated in this retrospective cohort study. AT was defined with ESID Criteria. Designated physicians in each healthcare center reviewed medical records of 218 patients with AT. Data from 218 patients with AT were analyzed. Mean ± standard deviation ages at symptom onset and diagnosis were 1.6 ± 1.1 and 5.7 ± 3.5 years, respectively. Most (66.9%) patients presented recurrent airway infections, which was significantly associated with IgA deficiency. Humoral deficiencies included IgA deficiency in 60.8% of patients and IgG deficiency in 28.6%. Lymphopenia was present in most cases, mainly affecting T and B cells. Around half of patients used antibiotic prophylaxis (57.7%) and immunoglobulin replacement (49.1%). No complications due to live viral vaccines were reported. Their mean survival was 24.2 years and Kaplan-Meier 20-year-survival rate was 52.6%. Low IgG levels were associated with decreased life expectancy (hazard ratio 2.1; 95% CI, 1.11–3.93), whereas male sex was a protecting factor (hazard ratio 0.52; 95% CI, 0.27–0.99). There was a high frequency of recurrent infections and immunologic abnormalities in our sample of patients with AT. Higher mortality was associated with female gender and low IgG levels. These findings suggest that immunologic status should be investigated in all patients with AT, thus helping us to improve therapeutic strategies.

  • Immunoglobulin G and subclasses placental transfer in fetuses and preterm newborns: a systematic review

    by Renan Augusto Pereira, Versiéri Oliveira de Almeida, Lennon Vidori, Maurício Obal Colvero, Sérgio Luís Amantéa

    Immunoglobulin G (IgG) and subclasses are the only class of antibodies capable of crossing placenta and providing protection against neonatal infectious diseases, especially in premature infants. This systematic review aimed to review the literature concerning the transplacental transfer of IgG and its subclasses in fetuses and preterm newborns and compare the results with data from term neonates. Eleven studies were included in the final review. Most studies demonstrated a lower transplacental passage of IgG2 than other subclasses in term and preterm newborns and a more efficient passage of total IgG and IgG1 after 37 weeks of gestational age. These results elucidate the physiology of IgG subclass transfer during pregnancy and may explain one of the reasons preterm newborns are especially susceptible to specific pathogens, such as encapsulated bacteria.


  • Open Access

    Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta‐analysis

    by Renan A. Pereira, Versiéri Oliveira de Almeida, Mariana Zambrano, Linjie Zhang, Sérgio L. Amantéa

    Background: Nebulized epinephrine and hypertonic saline have been extensively studied in infants with acute bronchiolitis, with conflicting results.Aims: To evaluate the efficacy on length of stay (LOS), clinical severity scores (CSS), oxygen saturation (SaO2), and safety profile of nebulized epinephrine plus hypertonic saline (HS) in infants with acute bronchiolitis.Materials & Methods: This is a systematic review and meta‐analysis. Outcomes were represented by mean differences (MD) or standard mean differences (SMD) and 95% confidence intervals (CIs) were utilized.Results: Eighteen trials were systematically selected and 16 of them contributed to the meta‐analysis (1756 patients). Overall, a modest but significant positive impact was observed of the combination therapy on LOS (MD of –0.35 days, 95% CI −0.62 to −0.08, p = 0.01, I2 = 91%). Stratification by time of CSS assessment unveiled positive results in favor of the combination therapy in CSS assessed 48 and 72 h after the admission (SMD of −0.35, 95% CI −0.62 to −0.09, p = 0.008, I2 = 41% and SMD of −0.27, 95% CI −0.50 to −0.04, p = 0.02, I2 = 0%, respectively). No difference in SaO2 was observed. Additional data showed a consistent safety profile, with a low rate of adverse events (1%), most of them mild and transient.Conclusion: Low‐quality evidence from this systematic review suggests that nebulized epinephrine plus HS may be considered as a safe and efficient therapy for decreasing LOS and CSS in infants with acute bronchiolitis, especially in those who require hospitalization for more than 48 h.


  • Open Access

    Neonatal diseases and oxidative stress in premature infants: an integrative review

    by Versiéri Oliveira de Almeida, Renan Augusto Pereira, Sérgio Luís Amantéa, Cláudia Ramos Rhoden, Maurício Obal Colvero


  • Open Access

    Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: a systematic review and meta-analysis

    by Renan Pereira, Versiéri Almeida, Mariana Zambrano, Linjie Zhang, Sérgio Amantéa

    Management of acute bronchiolitis remains controversial due to lack of strong evidence-based data. Nebulized epinephrine and hypertonic saline have been studied in infants with bronchiolitis, with conflicting results. This systematic review and meta-analysis aimed to evaluate the efficacy on length of stay (LOS), clinical severity scores (CSS), oxygen saturation (SaO2) and safety profile of nebulized epinephrine plus hypertonic saline (HS) in infants with acute bronchiolitis. Outcomes were represented by mean differences (MD) or standard mean differences (SMD) and 95% confidence intervals (CIs) were utilized. 18 trials were systematically selected and 16 of them contributed for the meta-analysis (1,756 patients). Overall, a modest but significant positive impact was observed of the combination therapy on LOS (MD of – 0.35 days, 95% CI -0.62 to -0.08, p = 0.01, I2 = 91%). Stratification by time of CSS assessment unveiled positive results in favor of the combination therapy in CSS assessed 48 hours and 72 hours after the admission (SMD of -0.35, 95% CI -0.62 to -0.09, p = 0.008, I2 = 41% and SMD of -0.27, 95% CI -0.50 to -0.04, p = 0.02, I2 = 0%, respectively). No difference in SaO2 was observed. Additional data showed a consistent safety profile, with a low rate of adverse events (1%), most of them mild and transient. In conclusion, nebulized epinephrine plus HS may be considered as a safe, cheap and efficient alternative for decreasing LOS and CSS in infants with acute bronchiolitis, especially on those who require more than 48 hours of hospitalization.


  • Open Access

    A porcine model for teaching surgical cricothyridootomy

    by Fernando Antonio Campelo Spencer Netto, Patricia Zacharias, Raphael Flavio Fachini Cipriani, Michael De Mello Constantino, Michel Cardoso, Renan Augusto Pereira

    OBJECTIVE: To evaluate the acceptability of an educational project using A porcine model of airway for teaching surgical cricothyroidotomy to medical students and medical residents at a university hospital in southern Brazil.METHODS: we developed a teaching project using a porcine model for training in surgical cricothyroidotomy. Medical students and residents received lectures about this surgical technique and then held practical training with the model. After the procedure, all participants filled out a form about the importance of training in airway handling and the model used.RESULTS: There were 63 participants. The overall quality of the porcine model was estimated at 8.8, while the anatomical correlation between the model and the human anatomy received a mean score of 8.5. The model was unanimously approved and considered useful in teaching the procedure.CONCLUSION: the training of surgical cricothyroidotomy with a porcine model showed good acceptance among medical students and residents of this institution.